Clinical governance

Through regulation and governance, we deliver the latest evidence-based treatments in a safe and high-quality environment.

Governance

At GenesisCare, through regulation and governance, we deliver the latest evidence- based treatments in a safe and high-quality environment.

Our Clinical Governance Committee sets safe and effective treatment protocols, reviews pathways, manages risk and works with the CQC. All consultant practising privileges are reviewed and continuously validated by our Medical Advisory Committee. Cases outside standard protocol are referred to our Clinical Advisory Team to peer review and recommend the best treatment plan.

Our Clinical Leaders Forum consists of leading practitioners in all fields of oncology working with GenesisCare to spearhead best practice and innovations, and expand our referral network.

Our Clinical Reference Groups specialising in breast, prostate, SABR and haematology oversee the continuous process of clinical evaluation, using peer-group collaboration and data-driven insights to design and implement standardised treatment protocols across our centres.

SABR Reference Group

Delivering clinical excellence

We are committed to an environment of clinical excellence, objectivity and accountability. Our SABR service is spearheaded by the SABR Reference Group – an advisory team of leading NHS clinicians who have been recruited due to their clinical expertise, each with a high volume of SABR cases performed, in order to form the UK’s leading SABR consortium.  

The role of the SABR Reference Group is to provide the necessary clinical oversight for a safe and effective SABR service across the GenesisCare network. This includes improved access to SABR treatments, introducing new clinicians to the SABR network, overseeing training and competency frameworks and contributing to the evidence base. In addition, they drive the implementation of existing and emerging radiation technologies, in particular the MRIdian for MR-guided SABR, with responsibility for the treatment network as well as academic collaboration with the University of Oxford.  

Group members also comprise the SABR Advisory Team (SAT) who lead the multidisciplinary teams and assess all referrals through the eMDT.  

SABR Reference Group

Dr James Good | Clinical Director of Stereotactic Radiotherapy Clinical Oncologist

Birmingham, Oxford

Special clinical interest in colorectal, hepato-pancreato-biliary, and head and neck cancers.

 

Dr Philip Camilleri | Clinical Director of Urological Cancers Clinical Oncologist

Milton Keynes, Oxford

Special clinical interest in urological cancers.

 

Dr John Conibear | Clinical Oncologist

Chelmsford, London

Special clinical interest in thoracic cancers and breast cancers.

 

Dr Veni Ezhil | Clinical Oncologist

London, Guildford, Oxford

Special clinical interest in thoracic cancers and lymphoma.

 

Dr Andy Gaya | Clinical Oncologist

London, Maidstone, Oxford

Special clinical interest in upper and lower, gastrointestinal and hepato-pancreato-biliary cancers.

 

Dr Alex Martin | Clinical Oncologist

Cambridge, London

Special clinical interest in thoracic cancers and urological cancers.

 

Dr Sherif Raouf | Clinical Oncologist

Chelmsford, London

Special clinical interest in colon, gynaecology, lower and upper GI, and lung.

Urology SABR Advisory Team

The Urology SABR Advisory Team is comprised of leading oncologists specialising in urology and is responsible for reviewing all referrals to the GenesisCare SABR service for urological cancers, including kidney and prostate.

Urology SABR Advisory Team

Dr Philip Camilleri | Clinical Director of Urological Cancers Clinical Oncologist

Milton Keynes, Oxford

Special clinical interest in urological cancers.

 

Dr Nicola Dallas | Clinical Oncologist

Oxford, Windsor

Special clinical interest in urological cancers, head and neck and thyroid cancer.

 

Dr Prantik Das | Clinical Oncologist

Nottingham, Oxford

Special clinical interest in urological cancers, bladder, stomach, neuroendocrine and lung.

 

Dr Dan Ford | Clinical Oncologist

Birmingham

Special clinical interest in urological cancers.

 

Dr Carla Perna | Clinical Oncologist

London, Guildford, Oxford

Special clinical interest in urological cancers and brochytherapy.

Urology Reference Group

Committed to clinical excellence

We are committed to an environment of clinical excellence, objectivity and accountability. Our prostate service is led by our Urology Reference Group – an advisory team of leading NHS clinicians who have been recruited due to their clinical expertise and experience in the techniques offered in the GenesisCare pathway. The role of the Urology Reference Group is to provide the necessary clinical oversight for a safe and effective uro-oncology service across the GenesisCare network from rapid access diagnostic clinics, through to advanced radiotherapy treatments and Theranostics.  

This includes improved access to treatment, introducing new clinicians to the network, overseeing training and competency frameworks and contributing to the evidence base. They also implement a quality framework and measurement for VMAT radiotherapy and spacers.  

In addition, they drive the implementation of existing and emerging radiation technologies, in particular the MRIdian for treatment of prostate cancer, as well as academic collaboration with the University of Oxford.  

Urology Reference Group

Dr Philip Camilleri | Clinical Director of Urological Cancer Clinical Oncologist

Milton Keynes, Oxford

Special clinical interest in urological cancers.

 

Mr Philip Charlesworth | Clinical Director of Urological Cancer Urological Surgeon

Windsor

Special clinical interest in urological cancers such as prostate cancer and bladder cancer.

 

Dr Nicola Dallas | Clinical Oncologist

Oxford, Windsor

Special clinical interest in urological cancers, head and neck and thyroid cancer.

 

Dr Prantik Das | Clinical Oncologist

Nottingham, Oxford

Special clinical interest in urological cancers, bladder, stomach, neuroendocrine and lung.

 

Mr Alan Doherty | Urologist

Birmingham

Special clinical interest in genito-urinary and prostate cancers.

 

Dr Dan Ford | Clinical Oncologist

Birmingham

Special clinical interest in urological cancers.

 

Dr Ruth McPherson | Radiologist

Oxford

Special clinical interest in urological cancers.

 

Dr Carla Perna | Clinical Oncologist

London, Guildford, Oxford

Special clinical interest in urological cancers and brochytherapy.

Breast Reference Group

The Breast Clinical Reference Group has been formed to support delivery of the Breast Service of Future strategy that was launched in November 2018. The roles of the group include introduction of new protocols and clinical trials, development of the eMDT platform and our genetic pathways, definition and collection of PROMs for all breast cancer patients, launching and promoting One Stop Breast Clinics. 

Breast Reference Group

Dr Russell Burcombe | Clinical Director

Consultant Clinical Oncologist with private practice at GenesisCare Maidstone. His NHS practice is at the Kent Oncology Centre, Maidstone & Tunbridge Wells NHS Trust. Russell has a particular interest in providing patient-friendly information, recently in an electronic App format, and is working with GenesisCare to deliver a patient portal. He is key in developing PROMs for breast cancer patients at GenesisCare. 

 

Miss P. G. Roy | Consultant Oncoplastic Breast Surgeon

Consultant Oncoplastic and Reconstructive Breast Surgeon in Oxford since 2011. She only performs breast surgery and offers all aspects including breast cancer surgery, reconstruction surgery and cosmetic surgery.

 

Dr Eliot Sims | Clinical Oncologist

Consultant Clinical Oncologist with private practice at GenesisCare Chelmsford and NHS base at Queen’s Hospital Romford and King George Hospital Ilford. Eliot is passionate about evidence-based cancer care and is currently leading on the implementation of the Breast Service of the Future eMDT strategy. 

 

Dr Fleur Kilburn Toppin | Specialist Advisor, Radiology 

Consultant Radiologist at Cambridge University Hospital Breast Unit with private practising privileges at GenesisCare Cambridge. Fleur is working with Simon to develop the One Stop Breast Clinics at GenesisCare and is also interested in breast screening and personalised imaging surveillance for patients. 

 

Dr Sileida Oliveros | Specialist Advisor 

Sileida is passionate about technical aspects of breast radiotherapy, evidence-based practice and advance radiotherapy techniques, including implementation of Partial Breast Irradiation at GenesisCare. She is also interested in establishing robust genetic and genomic pathways. 

Neuro-oncology Reference Group

A focus on clinical excellence to deliver neuro-oncology services

We are committed to creating an environment of clinical excellence for SRS and neuro-oncology services. Our protocols are adapted from international best practice and overseen by a core team of specialists selected on the basis of their extensive experience and high-quality credentials. Their key role is to align the neuro-clinical service with evidence-based treatments such as SRS to ensure safe, consistent care across all of our centres. This robust forum guides all aspects of clinical governance, patient selection, peer review, education, research and assessment of new clinicians to the neuro-oncology team.

In particular, the Clinical Reference Group form the backbone of our eMDT system – a multidisciplinary team-working platform that connects our experts with a wider group of referring clinicians to discuss and review patient care.

Clinical Reference Group

The Clinical Reference Group take carriage of crafting a clinical strategy that encompasses widening access, improving quality and delivery efficiency. Their key role is to align the neuro-clinical service with evidence-based treatments such as SRS to ensure safe and consistent care.

Neuro-oncology Reference Group

Dr Anup Vinayan | Clinical Director for Neuro-oncology Clinical Oncologist

London, Elstree

Special clinical interest in stereotactic radiosurgery such as Cyberknife and Gamma knife (primary brain, brain metastases and central nervous system).

 

Prof Puneet Plaha | Clinical Director for Neuro-oncology Consultant Neurosurgeon

Oxford

Special clinical interest in awake surgery and minimally invasive endoscopic brain tumour surgery.

 

Dr Luis Aznar-Garcia | Clinical Oncologist

Nottingham

Special clinical interest in hepato-pancreato-biliary, breast cancers, SBRT and stereotactic radiosurgery (brain metastases, benign tumours and spine).

 

Dr Meera Nandhabalan | Clinical Oncologist

Oxford

Special clinical interest in stereotactic radiotherapy (gliomas and benign tumours).

 

Mr David Peterson | Neurosurgeon

London

Special clinical interest in tumours of the central nervous system, spinal degenerative disease and hydrocephalus and stereotactic radiosurgery on the Gamma knife.

Neuro-oncology MDT

The neuro-oncology multidisciplinary team (MDT) review all referrals and assess suitability for SRS. Referring clinicians are involved in decisions and are assured a fast response within five days.

Neuro-oncology MDT

Mr Richard Stacey | Neuro-oncology MDT Chair Neurosurgeon

Oxford

Special clinical interest in neuro-oncology and epilepsy.

 

Dr Luis Aznar-Garcia | Clinical Oncologist

Nottingham

Special clinical interest in hepato-pancreato-biliary, breast cancers, SBRT and stereotactic radiosurgery (brain metastases, benign tumours and spine).

 

Dr Meera Nandhabalan | Clinical Oncologist

Oxford

Special clinical interest in stereotactic radiotherapy (gliomas and benign tumours).

 

Mr David Peterson | Neurosurgeon

London

Special clinical interest in tumours of the central nervous system, spinal degenerative disease and hydrocephalus and stereotactic radiosurgery on the Gamma knife.

 

Prof Puneet Plaha | Clinical Director for Neuro-oncology Consultant Neurosurgeon

Oxford

Special clinical interest in awake surgery and minimally invasive endoscopic brain tumour surgery.

 

Mr Pieter Pretorius | Neuroradiologist

Oxford

Special clinical interest in diagnostic imaging of conditions of the central nervous system, spine, head and neck region including ENT and orbital conditions.

 

Mr Fintan Sheerin | Neuroradiologist

Oxford

Special clinical interest in diagnostic imaging of conditions of the central nervous system, spine and head and neck region.

 

Dr Anup Vinayan | Clinical Director for Neuro-oncology Clinical Oncologist

London, Elstree

Special clinical interest in stereotactic radiosurgery such as Cyberknife and Gamma knife (primary brain, brain metastases and central nervous system).

 

Prof Natalie Voets | Neuroimaging Scientist

Oxford

Special clinical interest in MRI, functional MRI and tractography.